Phase II Trial of Cetuximab in Combination With Chemotherapy (Carboplatin and Navelbine) for Patients With Platinum-resistant Head and Neck Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Vinorelbine
- Indications Head and neck cancer
- Focus Biomarker; Therapeutic Use
- Acronyms CCV-NKU; CECAVI
- 10 Jun 2017 Biomarkers information updated
- 13 Oct 2012 Status changed from recruiting to completed as reported by EudraCT.
- 21 Jun 2012 Actual initiation date (24 Aug 2009) added as reported by European Clinical Trials Database.